A new cancer “vaccine” that is injected directly into a single tumor has showed promising results when tested on a small group of lymphoma patients, according to a study published in the journal Nature Medicine on April 8.
Researchers at Mount Sinai Hospital in New York, who tested the experimental therapy on 11 lymphoma patients, found it triggers the person’s immune system to recognize and attack cancer cells throughout the body.
